Costly Treatments Effective for Multiple Sclerosis (MS) Patients

by Hannah Joy on  November 28, 2017 at 12:36 PM Research News
RSS Email Print This Page Comment bookmark
Font : A-A+

Multiple sclerosis (MS) patients who followed their medication schedules were found to have better physical outcomes and also the overall costs for care were higher, reveals a new study.

Researchers examined the insurance claims and medical records of 681 patients with MS.
Costly Treatments Effective for Multiple Sclerosis (MS) Patients
Costly Treatments Effective for Multiple Sclerosis (MS) Patients

The findings, published in the Journal of the American Osteopathic Association, are considered significant because it is harder to assess treatment results for patients with MS than for those with other chronic illnesses, making it difficult to determine whether the treatment benefits justify their cost.

Show Full Article


Researchers noted that the disease has few easily obtainable objective measures, like blood pressure or glucose levels.

For patients with MS, disease activity is primarily measured through imaging studies, which can identify new lesions in the event of a relapse. Those studies are expensive and aren't routinely performed or captured in a quantitative fashion.

"Payers often look at near-term improvement to determine whether a treatment is effective and worth the cost," says Carl Hoegerl, DO, a neurologist at the Liberty University College of Osteopathic Medicine and a co-researcher on this study.

"But the case for MS treatment becomes evident when you see that the rate of decline becomes much slower and less severe."

Comparing the experiences of MS patients with high adherence to treatments to those with low adherence, the study found patients with highest adherence reported the disease's physical impact as 14 percent less severe and the psychological impact 17 percent less severe.

Patients with high adherence also rated their level of disability 12 percent lower and believed their treatments to be 7 percent more effective.

Dr. Hoegerl said that patients with untreated MS face a sharper decline in their ability to walk and move. They can also experience pain, numbness and tingling in their extremities.

MS is the most common cause of neurologic disability in adults, with about 135 cases per 100,000 Americans. About 12,000 new cases of MS are reported annually. While there is no cure, 12 FDA-approved treatments are currently available for patients with the disease.

"As an osteopathic physician, I'm focused on partnering with patients to achieve their health goals, which for most MS patients involves maintaining their physical functions for as long as possible," said Dr. Hoegerl. "We know that proper treatment of MS improves the quality of patients' lives and extends them to almost the length of the average person."

The study was conducted at Geisinger Health System, an integrated delivery system in central and northeastern Pennsylvania that includes an insurance provider, Geisinger Health Plan.

The study included adults whose records included MS diagnostic codes and medication orders for MS therapies.

The two phase study of patients from January 1, 2004 to December 31, 2013 included a retrospective analysis of electronic health records and insurance claims plus a prospective analysis of self-reported medication adherence.

The health outcomes considered included inpatients admission, emergency room visits, outpatient appointments and health care costs. All-cause versus MS-related costs were calculated separately, with all costs adjusted for inflation to 2013 dollars.



Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive